Tamiflu pharmacokinetic clinical study

2012 Jan: Pharmahungary has got regulatory approval for the extension of a Tamiflu pharmacokinetic clinical study (ClinicalTrials.gov Identifier: NCT01130636). The study is sponsored by Pharmahungary and supported by F. Hoffman-La Roche. Patient recruitment is currently ongoing in the endemic season in Hungary.